# CLEC2D orchestrates immune evasion and intrinsic oncogenic signals to fuel triple-negative breast cancer

Source: [Biological sciences : nature.com subject feeds](https://www.nature.com/articles/s42003-026-11357-8) · 2026-11-22 · Life
Page: https://themorning.science/story/clec2d-orchestrates-immune-evasion-and-intrinsic-oncogenic-signals-to-fuel-tripl-190c32bd596bb99b
Kind: research · Impact: low

## In brief

- A Nature Communications-family paper (s42003-026-11357-8) reports that CLEC2D is involved in immune evasion in triple-negative breast cancer.
- The same study describes CLEC2D as contributing to intrinsic oncogenic signalling in this cancer subtype.
- The source material available is a journal feed listing with the title only, so the methods and results are not summarised here.

## Why it matters

Triple-negative breast cancer lacks the hormone-receptor and HER2 targets used in other breast cancers, so identifying molecules that help tumours evade immunity and drive growth may point to new research directions.

## Coverage

- [CLEC2D orchestrates immune evasion and intrinsic oncogenic signals to fuel triple-negative breast cancer](https://www.nature.com/articles/s42003-026-11357-8) — Biological sciences : nature.com subject feeds, 2026-11-22

Tags: breast cancer, triple-negative breast cancer, immune evasion, oncogenic signalling, clec2d

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
